Clever Leaves Holdings (Clever Leaves Holdings) Buildings And Improvements : $7.82 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Clever Leaves Holdings Buildings And Improvements?

Clever Leaves Holdings's quarterly buildings and improvements increased from Jun. 2023 ($7.74 Mil) to Sep. 2023 ($7.77 Mil) and increased from Sep. 2023 ($7.77 Mil) to Dec. 2023 ($7.82 Mil).

Clever Leaves Holdings's annual buildings and improvements declined from Dec. 2021 ($13.38 Mil) to Dec. 2022 ($7.66 Mil) but then increased from Dec. 2022 ($7.66 Mil) to Dec. 2023 ($7.82 Mil).

Clever Leaves Holdings Buildings And Improvements Historical Data

The historical data trend for Clever Leaves Holdings's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clever Leaves Holdings Buildings And Improvements Chart

Clever Leaves Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Buildings And Improvements

5.31

8.46

13.38

7.66

7.82

Clever Leaves Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Buildings And Improvements	Get a 7-Day Free Trial												7.66	7.66	7.74	7.77	7.82

Clever Leaves Holdings Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Clever Leaves Holdings (Clever Leaves Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Clever Leaves Holdings Inc (NAS:CLVR) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

19-B Parque Industrial Tibitoc, Tocancipá, Cundinamarca, Bodega, Colombia, BC, CAN

Website

https://www.cleverleaves.com

Clever Leaves Holdings Inc is a producer of pharmaceutical and consumer cannabis brands. The company operates and has investments in Canada, Colombia, Germany, Portugal, and the United States. The company operates in two reportable segments, 1. The Cannabinoid operating segment: is comprised of the Company's cultivation, extraction, and commercialization of cannabinoid products. 2. Non-Cannabinoid operating segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements.

Executives

Andres Fajardo	director, officer: President	CLEVER LEAVES HOLDINGS INC., 489 FIFTH AVENUE, 27TH FLOOR, NEW YORK NY 10017
Julian Wilches	officer: Chief Regulatory Officer	CLEVER LEAVES HOLDINGS INC., 489 FIFTH AVENUE, 27TH FLOOR, NEW YORK NY 10017
Hague Henry R Iii	officer: Chief Financial Officer	489 FIFTH AVENUE, 27TH FLOOR, NEW YORK NY 10017
Gary M Julien	director	ONE LANDMARK SQUARE, 22ND FLOOR, STAMFORD CT 06901
William Muecke	director	C/O CLEVER LEAVES HOLDINGS, 6501 CONGRESS AVE, SUITE 240, BOCA RATON FL 33487
David Kastin	officer: General Counsel	C/O VITAMIN SHOPPE, INC., SECAUCUS NJ 07094
Kyle Detwiler	director, officer: Chief Executive Officer	CLEVER LEAVES HOLDINGS INC., 489 FIFTH AVENUE, 27TH FLOOR, NEW YORK NY 10017
George J Schultze	10 percent owner	C/O SCHULTZE ASSET MANAGEMENT, LLC, 3000 WESTCHESTER AVENUE, PURCHASE NY 10577
Elisabeth H Demarse	director	CREDITCARDS.COM, 13809 RESEARCH BOULEVARD, SUITE 906, AUSTIN TX 78750
Etienne H. Deffarges	director	ACCRETIVE HEALTH, INC., 401 NORTH MICHIGAN AVENUE, SUITE 2700, CHICAGO IL 60611
Schultze Special Purpose Acquisition Sponsor, Llc	10 percent owner	800 WESTCHESTER AVENUE, SUITE 632, RYE BROOK NY 10573
Amit Pandey	officer: Interim CFO	CLEVER LEAVES HOLDINGS INC., 489 FIFTH AVENUE, 27TH FLOOR, NEW YORK NY 10017